FDA

Amgen

Pharma

NEJM retracts article on pivotal study for Amgen’s Tavneos

As Tavneos comes under intensifying pressure, Amgen faces a new hurdle with a leading medical journal’s retraction of the drug’s pivotal study data.

Eric Sagonowsky Jun 30, 2026 10:57am

FDA

Lilly, Regeneron among 7 chosen for FDA PreCheck Pilot Program

Jun 30, 2026 9:57am

red light stop light street traffic signal

Unicycive approval filing turned away by FDA again

Jun 30, 2026 9:03am

FDA stop sign

FDA snubs Sobi’s gout drug over manufacturing issues

Jun 29, 2026 11:04am

Food and Drug Administration

Regulatory tracker: FDA starts review of Sandoz's generic GLP-1

Jun 29, 2026 10:30am

FDA

FDA finds fault with Pinnacle’s photodynamic therapy videos

Jun 25, 2026 10:12am